Surviving the Blockbuster Syndrome
- 19 March 2004
- news
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 303 (5665) , 1796-1799
- https://doi.org/10.1126/science.303.5665.1796
Abstract
New technologies have sent drug company R&D costs soaring, but with no corresponding rise as yet in the number of new drugs. Executives are talking about mergers, reorganization, and other ways to kick-start their production engines.Keywords
This publication has 0 references indexed in Scilit: